ERBB2 and breast carcinoma: Of the 20 breast cancer cases positive for HER2 amplification according to FISH results, 18 (90%) were positive for HER2 amplification by MIP microarray analysis, using a threshold of 4 and more copies for tumor cells (Table 3).